January Therapeutics
Mark Simon is on the Board of Advisors at January Therapeutics.
This person is not in the org chart
This person is not in any offices
January Therapeutics
January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties.